Drug
Mycophenolic Acid clinical trials
Also written Mycophenolate Mofetil, Cellcept, Myfortic and Lilly-68618.
Keep track of what changes. Save the Mycophenolic Acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
420 studies that test it; most in 2006 (39)
| Year | Studies |
|---|---|
| 1997 | 3 |
| 1998 | 4 |
| 1999 | 7 |
| 2000 | 12 |
| 2001 | 5 |
| 2002 | 21 |
| 2003 | 18 |
| 2004 | 22 |
| 2005 | 25 |
| 2006 | 39 |
| 2007 | 28 |
| 2008 | 16 |
| 2009 | 24 |
| 2010 | 25 |
| 2011 | 7 |
| 2012 | 13 |
| 2013 | 18 |
| 2014 | 15 |
| 2015 | 15 |
| 2016 | 16 |
| 2017 | 14 |
| 2018 | 9 |
| 2019 | 5 |
| 2020 | 11 |
| 2021 | 9 |
| 2022 | 12 |
| 2023 | 9 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 9 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Lymphoma
- 20
Who runs them
Industry 78 · Other 346
Fred Hutchinson Cancer Center (37) · Hoffmann-La Roche (22) · National Institute of Allergy and Infectious Diseases (NIAID) (11) · M.D. Anderson Cancer Center (11) · Masonic Cancer Center, University of Minnesota (11) · Novartis Pharmaceuticals (10) · Sidney Kimmel Cancer Center at Thomas Jefferson University (6) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (6)
Often tested with
Tested in the same studies.
Tacrolimus (107) · Fludarabine (93) · Cyclophosphamide (85) · Cyclosporine (75) · Fludarabine phosphate (47) · Melphalan (29) · Sirolimus (27) · Antilymphocyte Serum (26)
Studies
Open first, then newest update. How each study uses Mycophenolic Acid is read from its arms, and is right about nine times in ten.
Testing it · 424
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingPhase 2National Cancer Institute (NCI)NCT07524530Written as Mycophenolate Mofetil
- Mycophenolate After Stem Cell Transplant for Systemic SclerosisNot yet recruitingPhase 2Ottawa Hospital Research InstituteNCT07734012Written as Mycophenolate Mofetil 1000 mg twice daily
- Allogeneic Hematopoietic Stem Cell Transplant for GATA2 MutationsRecruitingPhase 2National Cancer Institute (NCI)NCT01861106Written as Mycophenolate mofetil (MMF)
- A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of RecurrenceRecruitingPhase 4Ruijin HospitalNCT06468709Written as Glucocorticoids+MMF
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingPhase 2Stanford UniversityNCT07634536Written as Mycophenolate mofetil (MMF)
- Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung DiseaseRecruitingPhase 2Centre hospitalier de l'Université de Montréal (CHUM)NCT05785065Written as Mycophenolate Mofetil
- Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor TherapyRecruitingPhase 2Fox Chase Cancer CenterNCT07663422Written as Mycophenolate Mofetil plus prednisone
- The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyRecruitingPhase 2Children's Hospital Medical Center, CincinnatiNCT05538208Written as Mycophenolate Mofetil
- Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA NephropathyNot yet recruitingPhase 2Shaheed Suhrawardy Medical College and HospitalNCT07785128Written as Mycophenolate Mofetil (MMF)
- Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRRecruitingPhase 2/3University Hospital, AngersNCT02416388Written as Mycophenolic acid (MPA)
- Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell DiseaseRecruitingPhase 2University of Illinois at ChicagoNCT03121001Written as mycophenolate mofetil
- Allo HSCT Using RIC and PTCy for Hematological DiseasesRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT05805605Written as Mycophenolate Mofetil
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingPhase 1City of Hope Medical CenterNCT06996119Written as Mycophenolate Mofetil
- 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute LeukemiaRecruitingPhase 1/2Fred Hutchinson Cancer CenterNCT03128034Written as Mycophenolate Mofetil
- A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)RecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT05736419Written as Mycophenolate Mofetil
- Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain CancerNot yet recruitingPhase 2/3Alliance for Clinical Trials in OncologyNCT07605364Written as Mycophenolate Mofetil
- A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host DiseaseRecruitingPhase 2M.D. Anderson Cancer CenterNCT06973668Written as Mycophenolate Mofetil
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07566377Written as Mycophenolate Mofetil
- HORUS-Cytomegalovirus Open Proof-of-concept Exploratory TrialNot yet recruitingPhase 4Oriol ManuelNCT07570433Written as 50% reduction in the dose of MPA
- Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell TransplantationRecruitingPhase 2M.D. Anderson Cancer CenterNCT06807606Written as Mycophenolate mofetil
See all 424 studies that test Mycophenolic Acid →
Given in every arm · 289 — Mycophenolic Acid is usual care beside what is tested
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of ImmunityRecruitingPhase 2National Cancer Institute (NCI)NCT04339777Written as Mycophenolate mofetil (MMF)
- Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesRecruitingPhase 1/2National Cancer Institute (NCI)NCT05327023Written as Mycophenolate mofetil
- Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesRecruitingPhase 1/2National Cancer Institute (NCI)NCT04959175Written as Mycophenolate Mofetil
- A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) SyndromeRecruitingPhase 2National Cancer Institute (NCI)NCT05027945Written as Mycophenolate mofetil (MMF)
- Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell TransplantationRecruitingPhase 1National Cancer Institute (NCI)NCT07162038Written as Mycophenolate Mofetil
- A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney TransplantationRecruitingPhase 2/3SanofiNCT07412470Written as mycophenolate mofetil
- Belatacept in Heart TransplantationRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT06478017Written as Mycophenolate Mofetil/Sodium
- Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell TransplantationRecruitingPhase 2University of NebraskaNCT06799195Written as Mycophenolate Mofetil (MMF)
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsRecruitingPhase 2Hoffmann-La RocheNCT05039619Written as Mycophenolate Mofetil
- Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell TransplantationRecruitingPhase 1OHSU Knight Cancer InstituteNCT07548983Written as Mycophenolate Mofetil
- CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaRecruitingPhase 1Fred Hutchinson Cancer CenterNCT04375631Written as Mycophenolate Mofetil
- Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAMLRecruitingPhase 1/2Heinrich-Heine University, DuesseldorfNCT05807932Written as Mycophenolate Mofetil
- Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNINot yet recruitingPhase 1/2Peking University People's HospitalNCT07796620Written as MMF
- CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell TransplantationNot yet recruitingPhase 2Medical College of WisconsinNCT07808112Written as Mycophenolate Mofetil (MMF)
- A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive MedicationsRecruitingPhase 3Bristol-Myers SquibbNCT04877288Written as Mycophenolate Mofetil
- Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic DiseasesRecruitingPhase 2Fred Hutchinson Cancer CenterNCT06013423Written as Mycophenolate Mofetil
- Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary MyelofibrosisRecruitingPhase 2Fred Hutchinson Cancer CenterNCT04370301Written as Mycophenolate Mofetil
- Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantRecruitingPhase 1/2M.D. Anderson Cancer CenterNCT04022239Written as Mycophenolate Mofetil
- A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07359859Written as Mycophenolate Mofetil
- 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic SyndromeRecruitingPhase 1/2Fred Hutchinson Cancer CenterNCT03670966Written as Mycophenolate Mofetil
Showing 20 of 289.
As the comparator · 56 — what is tested is compared with Mycophenolic Acid
- Advancing Transplantation Outcomes in ChildrenRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT06055608Written as Mycophenolate Mofetil
- A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)RecruitingPhase 3Incyte CorporationNCT06615050Written as Mycophenolate mofetil (MMF)
- PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid ExposureNot yet recruitingPhase 2Therakos LLCNCT07619898Written as Mycophenolate Mofetil (MMF)
- Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver CancerEnrolling by invitationPhase 4Baylor Research InstituteNCT02081755Written as Myfortic
- Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host DiseaseRecruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06682169Written as Mycophenolate mofetil
- Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in KoreaNot yet recruitingPhase 4Chong Kun Dang PharmaceuticalNCT06942156Written as Mycophenolate mofetil Tablet/Capsule
- Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic SyndromeRecruitingPhase 2Children's Hospital of Chongqing Medical UniversityNCT05843968Written as Mycophenolate Mofetil
- Treatment FOr Corticosteroid Dependent UveitiSNot yet recruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT06258915Written as Mycophenolate Mofetil
- Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation RecipientsRecruitingPhase 4Lee's Pharmaceutical LimitedNCT06114953Written as Mycophenolate Mofetil
- A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic SyndromeCompletedPhase 3Hoffmann-La RocheNCT05627557Written as MMF
- Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE ScoreCompletedPhase 3Boston Children's HospitalNCT03386539Written as Mycophenolate Mofetil
- Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine ACompletedPhase 4University Hospital, BordeauxNCT02328963Written as mycophenolic acid
- MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant RecipientsCompletedPhase 4Chong Kun Dang PharmaceuticalNCT06044493Written as Mycophenolate mofetil Tablet/Capsule
- Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant PatientsActive, not recruitingPhase 4Chong Kun Dang PharmaceuticalNCT05193565Written as Mycophenolate mofetil
- Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus NephritisCompletedPhase 3The University of Hong KongNCT02630628Written as Mycophenolate mofetil
- A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)CompletedPhase 3Incyte CorporationNCT03112603Written as Mycophenolate mofetil (MMF)
- PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCTCompletedPhase 2St. Petersburg State Pavlov Medical UniversityNCT04669210Written as Mycophenolate Mofetil
- Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell TransplantationCompletedNot applicableZhejiang UniversityNCT04838704Written as Calcineurin Inhibitor+Methotrexate+Mycophenolate mofetil
- Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic SyndromeCompletedPhase 3Nilratan Sircar Medical CollegeNCT03899103Written as Mycophenolate Mofetil
- Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant RecipientsCompletedPhase 2Astellas Pharma Global Development, Inc.NCT02921789Written as Mycophenolate Mofetil (MMF)
Showing 20 of 56.
Codes
What other systems call Mycophenolic Acid · ClinicalTrials.gg INT007859
- MeSH (NLM) D009173Mycophenolic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) HU9DX48N0TMYCOPHENOLIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 7145Confirmed FDA, Wikidata
- Wikidata Q420553mycophenolic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C673Mycophenolic AcidOne source FDA
- DrugBank DB01024One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009173 | Mycophenolic Acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | HU9DX48N0T | MYCOPHENOLIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7145 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420553 | mycophenolic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C673 | Mycophenolic Acid | One source FDA |
| DrugBank | DB01024 | — | One source Wikidata |
Also registered as mycophenolate mofetil (UNII 9242ECW6R0 · RxNorm 68149), mycophenolate mofetil hydrochloride (UNII UXH81S8ZVB · RxNorm 237112) and mycophenolate sodium (UNII WX877SQI1G · RxNorm 408142).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.